141 related articles for article (PubMed ID: 6934421)
1. 1,25-dihydroxy-vitamin D3: a new treatment for hypoparathyroidism.
Glatthaar C; Smith R; Espiner EA; Donald RA; Hinton D
N Z Med J; 1980 Oct; 92(669):267-71. PubMed ID: 6934421
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
Kooh SW; Fraser D; DeLuca HF; Holick MF; Belsey RE; Clark MB; Murray TM
N Engl J Med; 1975 Oct; 293(17):840-4. PubMed ID: 170516
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol.
Hill LF; Davies M; Taylor CM; Standbury SW
Clin Endocrinol (Oxf); 1976; 5 Suppl():167S-173S. PubMed ID: 1052776
[TBL] [Abstract][Full Text] [Related]
4. Hypoparathyroidism during pregnancy: treatment with calcitriol.
Salle BL; Berthezene F; Glorieux FH; Delvin EE; Berland M; David L; Varenne JP; Putet G
J Clin Endocrinol Metab; 1981 Apr; 52(4):810-3. PubMed ID: 6894151
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children.
Rosen JF; Fleischman AR; Finberg L; Eisman J; DeLuca HF
J Clin Endocrinol Metab; 1977 Sep; 45(3):457-68. PubMed ID: 903398
[No Abstract] [Full Text] [Related]
6. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
Davies M; Taylor CM; Hill LF; Stanbury SW
Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
[TBL] [Abstract][Full Text] [Related]
7. Hypoparathyroidism and pregnancy. Treatment with calcitriol.
Sadeghi-Nejad A; Wolfsdorf JI; Senior B
JAMA; 1980 Jan; 243(3):254-5. PubMed ID: 7350374
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
Stamp TC
Curr Med Res Opin; 1981; 7(5):316-36. PubMed ID: 6894416
[TBL] [Abstract][Full Text] [Related]
9. Calcium imbalance in hypoparathyroidism.
Gupta MM
J Assoc Physicians India; 1991 Aug; 39(8):616-8. PubMed ID: 1669288
[TBL] [Abstract][Full Text] [Related]
10. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of 1,25-dihydroxy vitamin D3 and 24,25-dihydroxy vitamin D3 in renal osteodystrophy.
Muirhead N; Adami S; Sandler LM; Fraser RA; Catto GR; Edward N; O'Riordan JL
Q J Med; 1982; 51(204):427-44. PubMed ID: 6760236
[TBL] [Abstract][Full Text] [Related]
12. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
Kind HP; Prader A; DeLuca HF; Gugler E
Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
[No Abstract] [Full Text] [Related]
13. Treatment of hypocalcemia caused by hypoparathyroidism or pseudohypoparathyroidism with domestic-made calcitriol: a prospective and self-controlled clinical trial.
Wang O; Xing XP; Meng XW; Xia WB; Li M; Jiang Y; Hu YY; Liu HC
Chin Med J (Engl); 2009 Feb; 122(3):279-83. PubMed ID: 19236804
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol in disorders of bone and calcium metabolism.
Riggs BL
Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
[No Abstract] [Full Text] [Related]
16. [Treatment of psoriasis by oral calcitriol. A study of 5 cases and review of the literature].
Boisseau-Garsaud AM; Legrain V; Hehunstre JP; Maleville J; Taïeb A
Ann Dermatol Venereol; 1993; 120(10):669-74. PubMed ID: 8161095
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hypoparathyroidism. Trials of 1 alpha-hydroxycholecalciferol (1 alpha-(OH)D3)].
Jorgensen H; Vogt JH
Tidsskr Nor Laegeforen; 1977 Aug; 97(22):1069-72. PubMed ID: 905981
[No Abstract] [Full Text] [Related]
18. Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism.
Bell NH; Epstein S; Stern PH
N Engl J Med; 1979 Nov; 301(21):1183-4. PubMed ID: 492291
[No Abstract] [Full Text] [Related]
19. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
Kiilerich S; Christiansen C; Christensen MS; Naestoft J
Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
[TBL] [Abstract][Full Text] [Related]
20. The clinical use of synthetic 1,25-dihydroxycholecalciferol.
Evans IM; Boulton-Jones M; Doyle FH; Joplin GF; Lockwood M; Matthews EW; MacIntyre I
Calcif Tissue Res; 1976 Aug; 21 Suppl():236-41. PubMed ID: 782663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
